Stockscreener 앱 받기
6.02
4.33%
0.25
시간 외 거래:
6.01
-0.010
-0.17%
전일 마감가:
$5.77
열려 있는:
$5.81
하루 거래량:
109.10K
Relative Volume:
2.52
시가총액:
$101.07M
수익:
$49.98M
순이익/손실:
$-9.64M
주가수익비율:
-8.4789
EPS:
-0.71
순현금흐름:
$-4.86M
1주 성능:
-17.65%
1개월 성능:
-19.63%
6개월 성능:
+47.19%
1년 성능:
+17.35%
1일 변동 폭
$5.79
$6.39
1주일 범위
$5.64
$7.9375
52주 변동 폭
$3.6001
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
명칭
Champions Oncology Inc
전화
410-369-0365
주소
855 N. WOLFE STREET, BALTIMORE, NJ
CSBR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.02 | 101.07M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-12 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-11-18 | 개시 | The Benchmark Company | Speculative Buy |
Champions Oncology Inc 주식(CSBR)의 최신 뉴스
Champions Oncology Says It Has Obtained License to Use Radioactive Materials in Preclinical Studies - marketscreener.com
CSBR Secures License for Radioactive Material Use in Preclinical Studies | CSBR Stock News - GuruFocus
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House - Bellingham Herald
Press Release Distribution & PR Platform - ACCESS Newswire
Champions Oncology Unlocks Next-Gen Cancer Treatment Capabilities with Strategic Radiotherapy License - Stock Titan
Champions Oncology Reports Quarterly Revenue of $12.9 Million - ACCESS Newswire
Champions Oncology (CSBR) Partners with Turbine to Boost Drug Di - GuruFocus
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine - Stock Titan
Turbine Launches the World’s First Virtual Lab Using Cell Simulations - Business Wire
Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets - The Malaysian Reserve
Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets™ - PR Newswire UK
Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their respectable 47% return over the last year - Yahoo
I-Apollo Hospitals, yethula i-“Cancer Champions United” isinyathelo esiyingqayizivele sokunikeza amandla Abasinde Ngomdlavuza! - Apollo Hospitals
Patient Derived Xenograft Model Market Future Business - openPR.com
Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 - ACCESS Newswire
Investors Give Champions Oncology, Inc. (NASDAQ:CSBR) Shares A 28% Hiding - simplywall.st
American Battery Technology boosts recycled battery output - Investing.com
Apollo Hospitals, yakhazikitsa "Cancer Champions United" njira yapadera yopatsa mphamvu Opulumuka Khansa! - Apollo Hospitals
How To Trade (CSBR) - news.stocktradersdaily.com
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report - TradingView
Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024) - Yahoo Finance
Champions Oncology target raised to $12 at Craig-Hallum By Investing.com - Investing.com Canada
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Call Transcript - MSN
Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations By Investing.com - Investing.com South Africa
Champions Oncology Achieves Record Revenue and Profit - TipRanks
Champions Oncology earnings beat by $0.37, revenue topped estimates - Investing.com Canada
Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations - Investing.com
CHAMPIONS ONCOLOGY Earnings Results: $CSBR Reports Quarterly Earnings - Nasdaq
Champions Oncology stock surges as earnings beat expectations By Investing.com - Investing.com South Africa
Champions Oncology stock surges as earnings beat expectations - Investing.com India
Champions Oncology Reports Record Quarterly Revenue and Net Income - TradingView
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million - ACCESS Newswire
Stock Index Futures Gain After Yesterday’s Selloff, U.S. JOLTs Report in Focus - TradingView
Earnings Scheduled For March 11, 2025 - Benzinga
CHAMPIONS ONCOLOGY Earnings Preview: Recent $CSBR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Champions Oncology Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 - ACCESS Newswire
When Will Champions Oncology Report Q3 Results? Key Date for Oncology Research Leader - StockTitan
Champions Oncology Inc (CSBR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):